GEn1E Lifesciences Patents

Patent portfolio assigned to GEn1E Lifesciences (verified via public assignee records). Clinical-stage biotech (p38alpha/MK2 inflammation, ARDS). No direct product competitors named in public sources. BARDA is a development partner. Patent US20220135520A1 assigned to GEn1E Lifesciences Inc confirms has_patents=true; exact count not enumerable (Google Patents assignee page unreachable).